2024 World Bronchiectasis Conference Takeaways

Professor James Chalmers discusses the highlights from the World Bronchiectasis Conference held July 4-6, 2024 in Dundee, Scotland. Bronchiectasis is now considered an inflammatory disease, instead of an infectious disease. Professor Chalmers discussed the results from phase 3 (Brensocatib) and phase 2 (BI 1291583) drug trials that target neutrophilic inflammation in Bronchiectasis, along with other trial results, and answering questions.